At stage 3, tumour progression further downregulated IFN-γ levels of NK cells in Kras-mutated mice, and antibiotic treatment accelerated the IFN-γ decrease, while there was no significant change in TNF-α secretion of NK cells in the four groups (Figure 3(c)). This evidence concerns the gene KRAS and neoplasm.